IASLC 2020 Targeted Therapies of Lung Cancer Meeting
Feb 19 from 7:00 AM PST to Feb 21, 2020
Session: Immunotherapy Combinations
Title: A Phase 1 Study of ADXS-503 Alone and in Combination with Pembrolizumab in
Subjects with Metastatic Squamous or Non-Squamous Non-Small Cell Lung Cancer
Presenter: Dr. Jennifer Carlisle, Assistant Professor, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University
Date: Saturday, February 22, 2020
Time: 7:00 am PT
Title: A Phase 1 Study of ADXS-503 Alone and in Combination with Pembrolizumab in
Subjects with Metastatic Squamous or Non-Squamous Non-Small Cell Lung Cancer
Presenter: Dr. Jennifer Carlisle, Assistant Professor, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University
Date: Saturday, February 22, 2020
Time: 7:00 am PT
Location
Santa Monica, California